Nuvalent Inc vs Palantir Technologies Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Palantir Technologies Inc trades at $131.94 (market cap $323.28B). The key difference: Palantir Technologies Inc is far larger — about 33× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Palantir Technologies Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | PLTR | |
|---|---|---|
Market Cap | $9.81B | $323.28B |
Sector | Technology | Technology |
52-Week High | $123.96 | $207.18 |
52-Week Low | $72.16 | $107.27 |
Enterprise Value | $8.52B | $315.46B |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →